TD2 Precision Oncology
Pre-clinicalTD2, a leading oncology CRO, advances oncology research by guiding new oncology therapies from preclinical and clinical trial phases to FDA approval.
Founded
2003
Focus
OncologyDiagnostics
About
TD2, a leading oncology CRO, advances oncology research by guiding new oncology therapies from preclinical and clinical trial phases to FDA approval.
Funding History
3Total raised: $53M
Debt$10MSilicon Valley BankMar 15, 2020
Series B$28MUndisclosedJun 15, 2017
Series A$15MUndisclosedFeb 15, 2014
Company Info
TypePrivate
Founded2003
LocationScottsdale, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile